The databook is designed to serve as a comprehensive guide to navigating this
sector. The databook focuses on market statistics denoted in the form of
revenue and y-o-y growth and CAGR across the globe and regions. A detailed
competitive and opportunity analyses related to pharmaceutical manufacturing market will
help companies and investors design strategic landscapes.
conventional drugs (small molecules) was the
largest segment with a revenue share of
54.39% in
2023.
Horizon Databook has segmented the Global pharmaceutical manufacturing market based on biologics & biosimilars (large molecules), conventional drugs (small molecules) covering the revenue growth of each sub-segment from 2018 to
2030.
- Global Pharmaceutical Manufacturing Molecule Type Outlook (Revenue, USD Million, 2018-2030)
- Biologics & Biosimilars (Large Molecules)
- Monoclonal Antibodies
- Vaccines
- Cell & Gene Therapy
- Others
- Conventional Drugs (Small Molecules)
- Global Pharmaceutical Manufacturing Drug Development Type Outlook (Revenue, USD Million, 2018-2030)
- Global Pharmaceutical Manufacturing Formulation Outlook (Revenue, USD Million, 2018-2030)
- Tablets
- Capsules
- Injectables
- Sprays
- Suspensions
- Powders
- Other Formulations
- Global Pharmaceutical Manufacturing Routes of Administration Outlook (Revenue, USD Million, 2018-2030)
- Oral
- Topical
- Parenterals
- Inhalations
- Other Routes of Administration
- Global Pharmaceutical Manufacturing Therapy Area Outlook (Revenue, USD Million, 2018-2030)
- Cardiovascular Diseases
- Pain
- Diabetes
- Cancer
- Respiratory Diseases
- Other Diseases
- Global Pharmaceutical Manufacturing Prescription Requirements Outlook (Revenue, USD Million, 2018-2030)
- Prescription Medicines
- Over-the-counter (OTC) Medicines
- Global Pharmaceutical Manufacturing Age Type Outlook (Revenue, USD Million, 2018-2030)
- Children & Adolescents
- Adults
- Geriatric
- Global Pharmaceutical Manufacturing Sales Channel Outlook (Revenue, USD Million, 2018-2030)
Reasons to
subscribe to Global pharmaceutical manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of
Global pharmaceutical manufacturing market databook
-
Our clientele includes a mix of pharmaceutical manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed
overview of
global-level
data and insights on the Global pharmaceutical manufacturing market , including
forecasts for subscribers. This
global
databook contains high-level insights into
Global pharmaceutical manufacturing market from
2018 to
2030, including revenue
numbers, major trends, and company profiles.